Interactions of lactone, carboxylate and self-aggregated forms of camptothecin with human and bovine serum albumins

被引:47
作者
Fleury, F
Kudelina, I
Nabiev, I
机构
[1] UNIV REIMS,LAB SPECT BIOMOL,UFR PHARM,F-51096 REIMS,FRANCE
[2] RUSSIAN ACAD SCI,OPT SPECT DIV,SHEMYAKIN & OVCHINNIKOV INST BIOORGAN CHEM,MOSCOW 117871,RUSSIA
基金
俄罗斯基础研究基金会;
关键词
topoisomerase inhibitor; circular dichroism; camptothecin; human serum albumin;
D O I
10.1016/S0014-5793(97)00204-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pronounced differences in the interactions of monomeric (lactone and carboxylate) and the J-type self-aggregated form of camptothecin (CPT), an inhibitor of DIVA topoisomerase (topo) I, with human (HSA) and bovine (BSA) serum albumins were observed by using circular dichroism (CD) spectroscopy, HSA binding changes the geometry of the covalent structure of CPT due to hydrophobic contacts of the chromophore within the protein interior, The carbonyl group of the ring D of CPT (Fig. 1A) interacts with the positively charged amino acid residues of HSA. Interaction with HSA induces disaggregation of the J-type self-aggregates of CPT, On the other hand, neither heat-denatured HSA nor native BSA participated in binding of the lactone or carboxylate or self-aggregate forms of CPT, Analysis of HSA and BSA homology within the TIA and IIIA principle ligand-binding structural domains suggests that the binding site for the CPT chromophore is located in subdomain IIA, Hydrophobic contacts with Leu-203, Phe-211, and Ala-215 and electrostatic interactions with Lys-199 and/or Arg-222 of HSA may play a key role in formation of the drug-HSA complex. (C) 1997 Federation of European Biochemical Societies.
引用
收藏
页码:151 / 156
页数:6
相关论文
共 21 条
[1]  
BROWN JR, 1976, FED PROC, V35, P2141
[2]   LIPID BILAYER PARTITIONING AND STABILITY OF CAMPTOTHECIN DRUGS [J].
BURKE, TG ;
MISHRA, AK ;
WANI, MC ;
WALL, ME .
BIOCHEMISTRY, 1993, 32 (20) :5352-5364
[3]   THE STRUCTURAL BASIS OF CAMPTOTHECIN INTERACTIONS WITH HUMAN SERUM-ALBUMIN - IMPACT ON DRUG STABILITY [J].
BURKE, TG ;
MI, ZH .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (01) :40-46
[4]   STRUCTURE OF HUMAN SERUM-ALBUMIN [J].
CARTER, DC ;
HE, XM .
SCIENCE, 1990, 249 (4966) :302-303
[5]  
CHARNEY E, 1973, MOL BASIS OPTICAL AC, P364
[6]  
Clar E., 1952, AROMATISCHE KOHLENWA
[7]  
FLEURY F, 1996, RAMAN SPECTROSCOPY, P1128
[8]  
Frank-Kamenetsky M. D., 1971, Opt. Spectrosc, V30, P1092
[9]  
GANESTE P, 1981, TETRAHEDRON LETT, V22, P949
[10]   EUKARYOTIC DNA TOPOISOMERASES-I [J].
GUPTA, M ;
FUJIMORI, A ;
POMMIER, Y .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1995, 1262 (01) :1-14